Coalition for Epidemic Preparedness innovations
room Skøyen Atrium, Askekroken 11, 0277 Oslo
arrow_back See all Activities

Research and development of vaccines

IATI Identifier:

Published on IATI
  • date_range Aug 30, 2016
  • autorenew Implementation (Status)

CEPI 1.0 CEPI’s mission is to stimulate and accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks. The budget presented in this activity includes all investments + operating expenses and financial costs. • CFP1 on priority pathogens for EIDs: Launched January 2017 for the diseases Lassa, Nipah and MERS. The decision on priority diseases departed from pathogens identified by the WHO Blueprint for Action, followed by an in-depth assessment by the SAC. In recommending priority diseases to the CEPI Board, the SAC applied criteria related to 1) public health impact (potential of outbreak, transmissibility, burden of disease) and 2) feasibility (current scientific knowledge, pipeline candidates available). • CFP2 on platform technologies: Launched October 2017 to enable rapid vaccine development against both known and unknown pathogens that trigger infections with epidemic potential. A requirement is to produce sufficient vaccine doses to impact an emerging outbreak and that the platform demonstrates versatility one of the priority pathogens from the WHO Blueprint list. • CEPI’s third call for proposals (CfP3i) was for the development of human vaccines against Rift Valley fever and Chikungunya diseases. Rift Valley fever disease is included among the WHO R&D Blueprint list of priority pathogens in 2018, while Chikungunya is deemed to present a major public health risk where further R&D is needed. The call for proposals closed on March, 2019. • In addition to the vaccine development projects, CEPI has made several investments within the Enabling Science area, like biological standards and assays, data collection & scientific research, epidemiology and clinical development. • A global consortium is supporting the Government of the Democratic Republic of the Congo (DRC) to introduce a second investigational Ebola vaccine as part of ongoing efforts to contain the outbreak in eastern DRC. The large-scale clinical trial, sponsored by the London School of Hygiene & Tropical Medicine (LSHTM), is designed to help prevent the spread of the epidemic, the second worst in history, beyond the currently affected areas in eastern DRC, and if possible gather crucial information about the effectiveness of the vaccine to be better prepared to fight Ebola in the future. COVID-19 In 2020 CEPI launched a new call for proposals to develop vaccines against novel coronavirus, COVID-19. COVID-19 data is included in a separate IATI activity.

more_horiz
Sectors:

  • Infectious disease control

Participating Organisations

Bill & Melinda Gates Foundation Foundation Funding
Wellcome Trust Foundation Funding
The Government of Norway Government Funding
Government of Japan Government Funding
The Government of Belgium Government Funding
Government of Australia Government Funding
The Government of the United Kingdom Government Funding
International AIDS Vaccine Initiative International NGO Implementing
IDT biologica Private Sector Implementing
Inovio Pharmaceuticals Private Sector Implementing
University of Oxford, The Academic, Training and Research Implementing
Themis Bioscience Private Sector Implementing
University of Tokyo Academic, Training and Research Implementing
CureVac Private Sector Implementing
Imperial College Academic, Training and Research Implementing
University of Queensland Academic, Training and Research Implementing
PATH International NGO Implementing
Aurobindo Private Sector Implementing
Public Health Vaccines Private Sector Implementing
Emergent BioSolutions Private Sector Implementing
Colorado State University Academic, Training and Research Implementing
International Vaccines Institute International NGO Implementing
Larissa Other Implementing
Valneva Private Sector Implementing
BNITM Academic, Training and Research Implementing
Brighton Collaboration National NGO Implementing
INRB Local Government Implementing
LSHTM Academic, Training and Research Implementing
MSF France National NGO Implementing
University of Antwerpen Academic, Training and Research Implementing
Epicentre National NGO Implementing
Dalhousie Univesity Academic, Training and Research Implementing
FIND International NGO Implementing
Janssen Private Sector Implementing
NIBSC Other Public Sector Implementing
Tulane University Academic, Training and Research Implementing
CDV Mali Other Public Sector Implementing
University of North-Carolina Academic, Training and Research Implementing
Nigeria NCDC Other Public Sector Implementing
Benin FORS Academic, Training and Research Implementing
Government of Ethiopia Government Funding
European Commission Other Funding
Vulcan Private Sector Funding
Government of Canada Government Funding
The Government of Germany Government Funding
Government of Denmark Government Funding
Government of Finland Government Funding
Government of Indonesia Government Funding
The Government of Netherlands Government Funding
Government of Singapore Government Funding
Government of South Korea Government Funding
Government of Switzerland Government Funding
The Government of Saudi Arabia Government Funding
Taskforce for Global Health National NGO Implementing
University of Queensland Academic, Training and Research Implementing
Wageningen University & Research - Stichting Wageningen Research Academic, Training and Research Implementing
University of Pittsburgh Academic, Training and Research Implementing
Integrum Private Sector Implementing
Robert Koch Institute Academic, Training and Research Implementing
P-95 Private Sector Implementing
United States Agency for International Development Other Public Sector Funding
MERCK Private Sector Implementing
Technical University of Mombasa Academic, Training and Research Implementing
Medicines and Healthcare products Regulatory Agency (MHRA) Other Public Sector Implementing
Universiti Malaya Academic, Training and Research Implementing
Université Gamal Abdel Nasser de Conakry Academic, Training and Research Implementing
Connected DMV National NGO Implementing
Zalgen Labs Private Sector Implementing
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Academic, Training and Research Implementing

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range
Not Available Provider N/A Receiver N/A
date_range

Budget

0 USD
access_time Updated on May 30, 2022 10:16:58